Hologic (HOLX) Tops Q3 EPS by 4c; Offers Guidance

Hologic (NASDAQ: HOLX) reported Q3 EPS of $0.93, $0.04 better than the analyst estimate of $0.89. Revenue for the quarter came in at $984.4 million versus the consensus estimate of $959.92 million.

GUIDANCE:

Hologic sees Q4 2023 EPS of $0.80-$0.87, versus the consensus of $0.87. Hologic sees Q4 2023 revenue of $910-950 million, versus the consensus of $950 million.

Hologic sees FY2023 EPS of $3.87-$3.94, versus the consensus of $3.88. Hologic sees FY2023 revenue of $3995-4035 million, versus the consensus of $4020 million.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• AeroVironment restates quarterly financials, citing $89M goodwill error